Interest in low-dose radiotherapy to treat non-malignant conditions, including inflammatory and degenerative disorders of the joints and para-articular soft tissues, has increased substantially in recent years. The clinical efficacy is supported by a large body of evidence, but there is no consensus on the parameters for contouring the PTV. In this recording, Dr. Angel Montero from the Department of Radiation Oncology at the HM Hospitales in Madrid, describes a CT-based contouring atlas for delivering low-dose radiation in the symptomatic treatment of degenerative or inflammatory osteoarticular diseases.
Xstrahl to Highlight Superficial and Orthovoltage Radiotherapy Solutions for Skin Cancer and Selective Benign Conditions at ACRO Summit 2025 in Las Vegas
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Xstrahl 200, a modern orthovoltage radiotherapy solution for treating superficial lesions, skin cancers, and selective benign conditions. Visit Xstrahl at booth 220 at the ACRO Summit 2025 – The Radiation Oncology Summit located at Planet Hollywood, Las Vegas, NV from March 12-15, 2025.
